Acompanhe as Notícias da Recifes

A TV 3.0, também chamada oficialmente de DTV+, já chegou nas primeiras 22 cidades no Brasil. A nova geração da televisão aberta promete a maior mudança no setor desde 2007, quando o país iniciou a transição do sinal analógico para o digital. 📱 Veja as melhores promoções de celulares no WhatsApp do CT Ofertas Os primeiros conversores compatíveis já chegaram ao mercado, enquanto o sinal es

Blocking IL1RAP, a receptor that sits at a key control point in inflammatory signaling, can disrupt the tumor-driven inflammatory network that helps pancreatic cancer resist treatment, according to new research. Led by researchers at Sylvester Comprehensive Cancer Center, part of

The burning pain associated with cystitis affects millions of people around the world, and it can take days or even years for some patients to find relief from bladder pain, infection-related symptoms and the constant need to urinate. A new study led by Flinders University publis

The ongoing evolution of SARS-CoV-2, particularly the rapid emergence of the omicron variant and its sublineages, has weakened the effectiveness of existing vaccines and antiviral drugs, underscoring the potential risk of future coronavirus pandemics. In response, a joint researc

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), such as Ozempic or Wegovy, have revolutionized type 2 diabetes and weight-loss management, but they have also led to some unfortunate outcomes. A recent study in JAMA Psychiatry has raised concerns that GLP-1 medications may

According to new, independent research published in the Journal of the American Heart Association, GLP-1 receptor agonist (GLP-1 RA) medications reduce the number of deaths, amputations and hospitalizations among people with type 2 diabetes who also have narrowed leg arteries ass

For adults with type 2 diabetes mellitus (T2DM), bofanglutide, a glucagon-like peptide-1 receptor agonist, is associated with more meaningful reductions in hemoglobin A1C (HbA1c) levels than semaglutide, according to a study published online June 30 in the Annals of Internal Medi

University of Queensland researchers have developed a drug that activates a hard-to-target immune receptor—a breakthrough that could lead to new treatments for neurodegenerative conditions like motor neuron disease (MND).

Biohub researchers have performed what they believe is the first genome-wide CRISPR study of primary human adult skin cells, then used an AI model to mine the results for overlooked drug targets for psoriasis. They found an unlikely candidate: the receptor for oxytocin, a hormone

Over the past decades, some medical researchers and neuroscientists have been exploring the possible therapeutic effects of psychedelic compounds, such as lysergic acid diethylamide (LSD) and psilocybin. These are substances that act on serotonin receptors in the brain and can al

Rat disease models have played an integral role in scientific discovery and cancer research, including Nobel Prize–winning work from Charles Huggins on hormone therapy for prostate cancer in 1966. However, technical challenges in genetic engineering of rat models have limited the

Although opioids remain indispensable for pain relief in patients with advanced cancer, their use frequently results in OIC, which can substantially reduce quality of life and, in some cases, compromise the continuation of optimal pain management. Naldemedine, a peripherally acti